humanized antitissue factor monoclonal antibodies (Centocor)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namehumanized antitissue factor monoclonal antibodies (Centocor)
Drug Alias NameCNTO-859CNTO-860TF-5G9
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTissue factor inhibitors
TargetsTissue factor
Therapy Area/IndicationsBreast NeoplasmsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Biotech Inc
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsSepsis

Other Information

ATC CodeN/A
Related LinksN/A